Richter Gedeon stock gets a higher 2026 profit outlook

Published on 10/07/2026 at 13:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Richter Gedeon stock carries a 2026 pharma Clean EBIT outlook for double-digit growth after the August 7 report. First-half revenue rose 8.7 percent in constant currency.

Richter Gedeon, HU0000123096, Illustration mit AI erstellt.

Richter Gedeon (ISIN HU0000123096) was trading at HUF 12,390 on the Budapest Stock Exchange on October 7, 2026, up 0.16 percent from HUF 12,370. The main operating signal remains the company's upgraded 2026 pharma Clean EBIT outlook, announced with its first-half results on August 7, 2026.

Profit outlook moves into double digits

According to Yahoo Finance on August 7, 2026, management upgraded 2026 pharma Clean EBIT guidance to double-digit growth on a constant-currency basis. The same call reported first-half constant-currency revenue growth of 8.7 percent and a 21 percent increase in constant-currency Clean EBIT.

The figures point to a widening gap between top-line expansion and operating profit growth. That operating leverage is central to the investment case, although the company also said foreign-exchange effects reduced reported profitability in the first half.

Biotech and general medicines diverge

Biotechnology revenue growth reached 30 percent in constant currency in the first half of 2026, while management said the unit was moving closer to break-even than previously expected. General medicines remained the weaker business line, with distributor inventory rationalization and a weak flu season weighing on reported growth.

The call also highlighted a 25 percent increase in Reagila sales in Richter Gedeon's own commercial territories. Management expects general medicines to return to mid-single-digit growth, while the biotechnology business is expected to reach break-even by 2027, according to Yahoo Finance.

Analyst target stays above market price

Investing.com lists a Buy consensus from 7 analysts, with 3 Buy ratings, 4 Holds and 0 Sells. Its average 12-month target is HUF 13,214.6, or 6.66 percent above the HUF 12,390 market price, with targets ranging from HUF 9,435 to HUF 15,080.

Richter Gedeon stock holds at HUF 12,390

Richter Gedeon stock was trading at HUF 12,390 on October 7, 2026, with an intraday range of HUF 12,330 to HUF 12,440 and a 52-week range of HUF 9,380 to HUF 13,570. The market capitalization was HUF 2.3 trillion on the same date.